retatrutide glp-3 atomik labz Reta (GLP-3) 20mg Reta / GLP3-R - Prism

Retatrutide is promising because of its triple-agonist mechanism and strong weight-loss data, but current public evidence is not enough to make a firm superiority claim specifically for muscle preservation compared with semaglutide or tirzepatide

In terms of drug effectiveness, the main evaluation is the clinical effectiveness of the drug, the recommendation level of relevant authoritative professional information such as clinical guidelines or expert consensus

OR GCGR OR GLUCAGON OR (INCRETIN

Ambulatory blood pressure monitoring showed that tirzepatide actually reduces both systolic and diastolic blood pressure, partially offsetting any heart rate increase from a cardiovascular risk perspective